HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Abstract Full Text (PDF) All Versions of this Article: 285/2/H722    most recent 00691.2002v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (43) Citing Articles via Google Scholar Google Scholar Articles by Mochizuki, S. Articles by Kajiya, F. Search for Related Content PubMed PubMed Citation Articles by Mochizuki, S. Articles by Kajiya, F.

Role of hyaluronic acid glycosaminoglycans in shear-induced endothelium-derived nitric oxide release

¹Department of Medical Engineering, Kawasaki Medical School, Kurashiki 701-0192, Japan; ²Department of Medical Physics, Academic Medical Center, 1105 AZ Amsterdam, The Netherlands; and ³Department of Cardiovascular Physiology, Okayama University Graduate School of Medicine and Dentistry, Okayama 700-8558, Japan

Submitted 5 August 2002 ; accepted in final form 23 April 2003

	ABSTRACT

TOP ABSTRACT MATERIALS AND METHODS RESULTS DISCUSSION DISCLOSURES REFERENCES

 
Endothelium-derived nitric oxide (NO) is synthesized in response to chemical and physical stimuli. Here, we investigated a possible role of the endothelial cell glycocalyx as a biomechanical sensor that triggers endothelial NO production by transmitting flow-related shear forces to the endothelial membrane. Isolated canine femoral arteries were perfused with a Krebs-Henseleit solution at a wide range of perfusion rates with and without pretreatment with hyaluronidase to degrade hyaluronic acid glycosaminoglycans within the glycocalyx layer. NO production rate was evaluated as the product of nitrite concentration in the perfusate and steady-state perfusion rate. The slope that correlates the linear relation between perfusion rate and NO production rate was taken as a measure for flow-induced NO production. Hyaluronidase treatment significantly decreased flow-induced NO production to 19 ± 9% of control (mean ± SD; P < 0.0001 vs. control; n = 11), whereas it did not affect acetylcholine-induced NO production (88 ± 17% of pretreatment level, P = not significant; n = 10). We conclude that hyaluronic acid glycosaminoglycans within the glycocalyx play a pivotal role in detecting and amplifying the shear force of flowing blood that triggers endothelium-derived NO production in isolated canine femoral arteries.

glycocalyx; canine femoral artery; hyaluronidase; nitrite; shear stress

The biological functions of the glycocalyx have been studied in various aspects including regulation of vascular permeability (1) and suppression of platelet adhesion (16). Vink and Duling (17) recently reported that the glycocalyx layer forms a selective barrier against penetration of macromolecules such as dextrans and proteins. In high-oxidative-stress models, the glycocalyx layer is degraded (16), and it is well known that in high-oxidative-stress conditions such as hypertension and diabetes mellitus, flow-dependent vasodilation by NO production is impaired (3, 14). Thus it is physiologically and pathophysiologically important to clarify shear detection mechanisms for flow-induced NO production.

Pohl et al. (13) studied the interactions of endothelium-derived NO and myogenic constriction in saline-perfused rabbit mesenteric arteries and reported that vasodilation by stepwise flow increase was converted to vasoconstriction after biodegradation of sialic acid glycosaminoglycans within the glycocalyx by neuraminidase. Hecker et al. (8) reported that neuraminidase treatment inhibited shear stress-dependent NO production in rabbit femoral arteries that were perfused at a constant flow rate. Hyaluronic acid glycosaminoglycans (hyaluronan) are another main component of the glycocalyx layer. However, the roles of hyaluronic acid glycosaminoglycans for endothelial function have been investigated only partially, e.g., regulation of permeation of macromolecules from plasma to the endothelial surface (10). It is well known that one of the major endothelial functions is NO production, and we recently measured (12) electrochemically the intravascular NO level of isolated canine femoral arteries perfused at a wide range of perfusion rates and observed a linear increase in the NO level with increasing perfusion rate. In this study, we aimed at measuring flow-induced NO production from isolated arteries at a range of perfusion rates before and after degradation of hyaluronic acid glycosaminoglycans to clarify the role of hyaluronic acid glycosaminoglycans within the glycocalyx layer in the flow-sensing mechanisms for endothelium-derived NO production.

	MATERIALS AND METHODS

TOP ABSTRACT MATERIALS AND METHODS RESULTS DISCUSSION DISCLOSURES REFERENCES

 
Experimental procedures were approved by the Animal Research Committee of Kawasaki Medical School and conform with the standards for use of laboratory animals established by the Institute of Laboratory Animal Resources, National Academy of Sciences (US).

Chemicals. Modified Krebs-Henseleit bicarbonate buffer (in mM: 11 D-glucose, 1.2 MgSO₄, 12 KH₂PO₄, 4.7 KCl, 120 NaCl, 25 NaHCO₃, and 2.5 CaCl₂ · 2H₂O), hyaluronidase (hyaluronic acid hydrolase), -amino-n-caproic acid (plasmin inhibitor), and benzamidine hydrochloride (peptidase inhibitor) were purchased from Sigma (St. Louis, MO). BSA was supplied by Nacalai Tesque (Kyoto, Japan) and acetylcholine by Daiichi Pharmaceutical (Tokyo, Japan). Stock solutions of 1) hyaluronidase and 2) -amino-n-caproic acid and benzamidine hydrochloride were prepared with ultrapure water and frozen at –30°C until use. These stock solutions and BSA were mixed and diluted with Krebs buffer on the day of experiment (final concentrations: 14 µg/ml for hyaluronidase, 6.6 mg/ml for -amino-n-caproic acid, 1.6 mg/ml for benzamidine hydrochloride, 10 mg/ml for BSA). All solutions were purged with a mixed gas of 20% O₂-5% CO₂-75% N₂ and were kept at 37 ± 0.5°C and pH 7.4.

Animals and isolated vessel preparation. Adult mongrel dogs (n = 31) of either sex, weighing 10–32 kg, were initially sedated with ketamine (200 mg im) and anesthetized with pentobarbital sodium (30 mg/kg iv). Animals were then ventilated with a respirator pump (3–5 l O₂/min; model VS600, Instrumental Development, Pittsburgh, PA). These dogs were used mainly for other experimental studies on coronary circulation, and we isolated femoral arteries for the present study. A 6-cm-long segment of femoral artery (outer diameter 2.2–4.5 mm in situ) was isolated from each animal. Immediately after isolation, each artery was flushed with a heparinized saline solution, cannulated with a silicone tube through a plastic connector, and then placed in a bath containing Krebs buffer (37 ± 0.5°C) with the vessel length being kept to 6 cm (in vivo length). Here the proximal side of the vessel was connected to solution chambers and the distal side to a short tube for draining (sample collection for flow and nitrite measurements). These vessels were studied in a passive state without a constrictor, and also there was no spontaneous tone. The diameter was therefore constant throughout the experiment [confirmed by observation with a charge-coupled device (CCD) camera attached to a microscope].

Experimental protocol. First, the vessels were perfused with Krebs buffer within a wide range of perfusion rates (1.0–159.7 ml/min) to evaluate the control level of flow-induced NO production. Second, active hyaluronidase (n = 11) or heat-inactivated hyaluronidase (n = 10) was perfused for 20 min and then washed out with Krebs buffer for 10 min, and flow-induced NO production was measured again by perfusing Krebs buffer. Estimated shear stress ranged from 0.01 to 0.82 Pa (0.1–8.2 dyn/cm²). Here we followed previous protocols for hyaluronidase treatment (5, 15). Heat inactivation of hyaluronidase was performed by immersing the hyaluronidase stock solution in warm (90°C) water for 30 min. -Amino-n-caproic acid and benzamidine hydrochloride were not heat inactivated for both active and heat-inactivated hyaluronidase studies, to evaluate the sole effect of hyaluronidase treatment.

To confirm intactness of the endothelium and investigate the effect of hyaluronidase treatment on agonist-induced NO production from isolated canine femoral arteries (n = 10), acetylcholine was perfused at a constant perfusion rate before and after hyaluronidase treatment. First, 10 nM acetylcholine was perfused for 4 min to evaluate agonist-induced NO production by measuring the nitrite concentration in the perfusate and then washed out with Krebs-Henseleit buffer solution for 5 min before active hyaluronidase was perfused for 20 min to degrade the hyaluronic acid. After 10-min washout with Krebs buffer solution, acetylcholine was perfused again to evaluate agonist-induced NO production after degradation of hyaluronic acid. In each vessel, the perfusion rate was kept constant throughout the whole protocol to exclude possible effects of changes in shear stress on acetylcholine-induced NO production rate. Flow rate ranged from 16.2 to 21.7 ml/min (estimated shear stress: 0.06–0.07 Pa, 0.6–0.7 dyn/cm²).

Evaluation of NO production rate. Endogenous NO production rate was evaluated as the product of perfusion rate and nitrite concentration in the effluent. Perfusion rate was determined by timed collection; the weight of the effluent collected in a vial was measured by an electronic balance. About 200 µl of the effluent solution was collected after 3 min at each perfusion rate for measurement of nitrite concentration in the effluent. Nitrite was measured by a NOx analyzer (ENO-20; Eicom, Kyoto, Japan). The minimum detectable concentrations are <5 nM in pH-neutral solutions. In this study, we chose nitrite measurement instead of NO measurement by an NO sensor because of the high stability and easy analysis of nitrite in an aqueous solution. In preliminary studies, NO production rate of an isolated canine femoral artery did not change significantly in three or four runs of perfusion, indicating no changes in the relation between perfusion rate and NO production rate during the experimental period of each vessel.

Data analyses. Linear regression and correlation analyses were applied to evaluate the slope of the linear relation between perfusion rate and NO production rate. Changes in flow-induced NO production were evaluated as changes in the slope (normalized by control). Statistical analyses for the normalized values of the slopes and of acetylcholine-induced NO (nitrite) production were conducted by paired (control vs. after treatment with active or inactivated hyaluronidase; before and after hyaluronidase treatment for acetylcholine studies) or unpaired (after active hyaluronidase vs. after inactivated hyaluronidase) t-test. A value of P < 0.05 was considered statistically significant. Values are means ± SD.

	RESULTS

TOP ABSTRACT MATERIALS AND METHODS RESULTS DISCUSSION DISCLOSURES REFERENCES

 
The outer diameter of each vessel was constant throughout the experiment as confirmed by observation with a CCD camera attached to a microscope (data not shown). Perfusion pressure was <8 cmH₂O at the maximum perfusion rate for each vessel, indicating that in this study we observed the sole effect of shear stress by excluding the luminal pressure effect.

Figure 1 shows a representative result for flow-induced NO production before and after treatment with active hyaluronidase. The NO production rate increased linearly with increasing perfusion rate before enzymatic treatment (r² = 0.95). Hyaluronidase treatment significantly attenuated flow-induced NO production (decrease in slope from 0.084 to 0.009 nmol/ml). A linear relation between NO production rate and perfusion rate was also observed after enzymatic treatment (r² = 0.63).

View larger version (15K): [in this window] [in a new window]   Fig. 1. Relation between nitric oxide (NO) production rate from the isolated canine femoral artery and perfusion rate before () and after () treatment with 14 µg/ml hyaluronidase. Solid lines are a linear regression for each protocol (before: y = 0.084x – 0.055; after: y = 0.009x + 0.374).

Figure 2 shows a representative result for flow-induced NO production before and after treatment with heat-inactivated hyaluronidase. In sharp contrast to active hyaluronidase, treatment with heat-inactivated hyaluronidase did not cause any changes in flow-induced NO production. A linear relation between NO production rate and perfusion rate was again observed before and after enzymatic treatment (r² = 0.99 for both).

View larger version (15K): [in this window] [in a new window]   Fig. 2. Relation between NO production rate from the isolated canine femoral artery and perfusion rate before () and after () treatment with 14 µg/ml heat-inactivated hyaluronidase. Solid lines are a linear regression for each protocol (before: y = 0.066x + 0.019; after: y = 0.081x – 0.779).

Each data set, i.e., before or after enzymatic treatment, was then fitted with a linear regression line by the least-squares method (r² = 0.63–0.99), and the slope obtained was used as a measure of flow-induced NO production. Figure 3 summarizes the normalized slopes of the linear regression lines before and after treatment with active or heat-inactivated hyaluronidase. Here, the slope before treatment was used as control (100%). The normalized slope after active hyaluronidase treatment decreased significantly (19 ± 9% of control; P < 0.0001 vs. control; n = 11), whereas that after treatment with heat-inactivated hyaluronidase did not change [112 ± 19% of control; P = not significant (NS) vs. control, P < 0.0001 vs. active hyaluronidase; n = 10].

View larger version (13K): [in this window] [in a new window]   Fig. 3. Summary of the slopes of the linear correlation between perfusion rate and NO production rate. All values were normalized based on the slope before treatment (control, 100%). Control (open bar), after treatment with active hyaluronidase (hatched bar; P < 0.0001 vs. control; n = 11), and after treatment with heat-inactivated hyaluronidase [filled bar; P = not significant (NS) vs. control, P < 0.0001 vs. active hyaluronidase; n = 10] values are shown.

Figure 4 summarizes the normalized nitrite concentration in the perfusate after 4-min acetylcholine perfusion before and after treatment with active hyaluronidase. Here, the nitrite concentration before hyaluronidase treatment was used as control (100%) for normalization, because vessel size widely ranged from 3 to 4 mm in outer diameter, with possible variations in NO production among the vessels. Hyaluronidase treatment did not change acetylcholine-induced NO production significantly (88 ± 17% of pretreatment level; P = NS; n = 10). Acetylcholine-induced NO production rate excluding shear-induced NO was 0.6–2.7 nmol/min. This range of NO production rate for 10 nM acetylcholine is comparable to the flow-induced NO production rate at the perfusion rate applied.

View larger version (14K): [in this window] [in a new window]   Fig. 4. Summary of effect of hyaluronidase treatment on acetylcholine-induced NO production (n = 10). All values were normalized based on nitrite concentration before treatment. Pretreatment (open bar, 100%) and posttreatment (filled bar; P = NS) levels are shown.

	DISCUSSION

TOP ABSTRACT MATERIALS AND METHODS RESULTS DISCUSSION DISCLOSURES REFERENCES

 
The present study showed that degradation of hyaluronic acid glycosaminoglycans within the glycocalyx layer significantly decreases flow-induced endothelial NO production in canine femoral arteries, indicating that hyaluronic acid glycosaminoglycans are essential elements for detection and amplification of flow-induced shear force toward the endothelial cell membrane.

In this study, flow-induced NO production was studied within a wide range of perfusion rates (1.0–159.7 ml/min; estimated shear stress: 0.01–0.82 Pa, 0.1–8.2 dyn/cm²) and 80% NO production was inhibited by hyaluronidase treatment. Previously, Pohl et al. (13) investigated the role of sialic acid glycosaminoglycans of the rabbit mesenteric arteries and reported that neuraminidase treatment converted a net dilation to a net constriction when flow was increased 2.5 times control. Hecker et al. (8) studied the role of sialic acid glycosaminoglycans of rabbit femoral artery segments in flow-induced NO production at a constant perfusion rate of 0.17 ml/min and observed 64% inhibition after neuraminidase incubation. Thus it was demonstrated that not only sialic acid but also hyaluronic acid within the glycocalyx layer plays a pivotal role in flow-induced NO production. Here, a minimal amount of flow-induced NO production was still observed after hyaluronidase treatment. Recently, Van den Berg et al. (15) observed marked but incomplete removal of the glycocalyx layer of the rat myocardial capillary endothelium after hyaluronidase treatment by transmission electron microscopy. Therefore, the remaining low of degree NO production may have reflected incomplete degradation of hyaluronic acid glycosaminoglycans within the glycocalyx layer and/or residual shear-detection mechanisms including other glycocalyx components, membrane fluidity, and cytoskeleton structure as discussed below. It is also interesting to note that the linear relation between NO production rate and perfusion rate was still observed even after hyaluronidase treatment.

The results for acetylcholine-induced NO production imply that hyaluronic acid is involved only in shear-induced NO production and not in agonist-induced NO production. This is similar to the role of sialic acid glycosaminoglycans within the glycocalyx as observed by Pohl et al. (13).

Change in shear stress due to a change in anatomic inner vessel diameter by glycocalyx degradation is negligibly small for the type of vessels used in this study. For example, complete degradation of a glycocalyx layer of 0.2 µm thickness [observed by Henry and Duling (10) with FITC-dextrans and a fluorescence microscope and by Van den Berg et al. (15) with a transmission electron microscope] of a vessel of 3-mm inner diameter would lower shear stress by only 0.04%. This small change in shear stress is not expected to cause such a large change in NO production (12). Thus it is considered that the glycocalyx layer is directly involved in the enhanced shear detection for NO production.

The exact shear detection mechanism of the glycocalyx layer is still speculative. As extensively discussed by Henry and Duling (10), hyaluronic acid glycosaminoglycans seem to create a meshlike matrix by spanning other molecules such as glycoproteins and proteoglycans. Van den Berg et al. (15) recently observed the glycocalyx meshlike structure and degradation of the structure after hyaluronidase treatment in their transmission electron microscopy studies. Accordingly, it is speculated that the shear effect is enhanced by this meshlike structure and that degradation by hyaluronidase treatment thus creates a more open structure, decreasing shear force on this cell surface structure.

The signal transduction mechanisms between glycocalyx and NO synthase (NOS) are not yet clarified. In light of several previous studies, the following mechanisms may be hypothesized. Activation of pertussis toxin-refractory G proteins is needed for the first phase of shear-induced activation of endothelial NOS (11). Gudi et al. (6) reported that activation of G proteins is dependent on the fluidity of the phospholipid bilayer of liposomes. Interestingly, the membrane fluidity of cultured human umbilical vein endothelial cells increased linearly with increasing shear stress (7). Butler et al. (2) also studied the changes in endothelial cell membrane fluidity by changing shear stress and observed time-dependent and spatially heterogeneous changes in the membrane fluidity. Because glycosaminoglycans are associated with cell membrane and membrane proteins, it is thus conceivable that the glycocalyx layer senses and amplifies the shear effect, leading to changes in membrane fluidity, G protein activation, and NOS activation. Other possible shear-force transduction mechanisms include distortion and rearrangement of the cytoskeleton (4, 9). The enhanced shear effect by the glycocalyx may further enhance mechanical forces on the cytoskeleton structure, which is associated with membrane proteins and thus may interact with membrane fluidity. Therefore, we speculate that fluid shear is detected by the integrated mechanisms of these processes.

Vink et al. (16) recently reported that the glycocalyx of hamster cremaster muscle capillaries is transiently degraded after oxidized LDL infusion. It is thus implied that in high-oxidative-stress states such as hypertension and diabetes mellitus, the effect of shear stress stimuli is less than in normal states because of glycocalyx degradation, resulting in decreased NO production. This may be part of the mechanism for endothelial dysfunction in addition to NO deactivation with superoxide in high-oxidative stress subjects. In our preliminary study, we concomitantly perfused tiron, a superoxide scavenger, with active hyaluronidase. There was no change in the degradation effect of the enzyme (data not shown). Thus superoxide was not involved in the effects of hyaluronidase.

In conclusion, the hyaluronic acid glycosaminoglycans in the glycocalyx layer function as a shear-stress detection mechanism for shear-induced NO production.

	DISCLOSURES

TOP ABSTRACT MATERIALS AND METHODS RESULTS DISCUSSION DISCLOSURES REFERENCES

 
This study was supported in part by Grant-in-Aids for Scientific Research (B; 13555228) and (C; 13680961) from the Japanese Ministry of Education, Culture, Sports, Science, and Technology and by a grant from The Kidney Foundation, Japan.

	ACKNOWLEDGMENTS

 
The authors thank Dr. Takehiro Miyasaka and Chikako Tokuda for technical assistance.

	FOOTNOTES

 

Address for reprint requests and other correspondence: S. Mochizuki, Dept. of Medical Engineering, Kawasaki Medical School, 577 Matsushima, Kurashiki, Okayama 701-0192, Japan (E-mail: mochi{at}me.kawasaki-m.ac.jp).

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

	REFERENCES

TOP ABSTRACT MATERIALS AND METHODS RESULTS DISCUSSION DISCLOSURES REFERENCES

 

1. Baldwin AL and Thurston G. Mechanics of endothelial cell architecture and vascular permeability. Crit Rev Biomed Eng 29: 247–278, 2001.[ISI][Medline]
2. Butler PJ, Norwich G, Weinbaum S, and Chien S. Shear stress induces a time- and position-dependent increase in endothelial cell membrane fluidity. Am J Physiol Cell Physiol 280: C962–C969, 2001.[Abstract/Free Full Text]
3. Dakak N, Husain S, Mulcahy D, Andrews NP, Panza JA, Waclawiw M, Schenke W, and Quyyumi AA. Contribution of nitric oxide to reactive hyperemia: impact of endothelial dysfunction. Hypertension 32: 9–15, 1998.[Abstract/Free Full Text]
4. Davies PF. Flow-mediated endothelial mechanotransduction. Physiol Rev 75: 519–560, 1995.[Abstract/Free Full Text]
5. Dekker S, Vergroesen I, Vink H, and Spaan JAE. Hyaluronidase treatment of the endothelial cell glycocalyx stimulates flow-dependent endothelial NO release in the coronary circulation of dogs (Abstract). J Physiol 533P, 2001.
6. Gudi S, Nolan JP, and Frangos JA. Modulation of GTPase activity of G proteins by fluid shear stress and phospholipid composition. Proc Natl Acad Sci USA 95: 2515–2519, 1998.[Abstract/Free Full Text]
7. Haidekker MA, L'Heureux N, and Frangos JA. Fluid shear stress increases membrane fluidity in endothelial cells: a study with DCVJ fluorescence. Am J Physiol Heart Circ Physiol 278: H1401–H1406, 2000.[Abstract/Free Full Text]
8. Hecker M, Mülsch A, Bassenge E, and Busse R. Vasoconstriction and increased flow: two principal mechanisms of shear stress-dependent endothelial autacoid release. Am J Physiol Heart Circ Physiol 265: H828–H833, 1993.[Abstract/Free Full Text]
9. Helmke BP, Goldman RD, and Davies PF. Rapid displacement of vimentin intermediate filaments in living endothelial cells exposed to flow. Circ Res 86: 745–752, 2000.[Abstract/Free Full Text]
10. Henry CBS and Duling BR. Permeation of the luminal capillary glycocalyx is determined by hyaluronan. Am J Physiol Heart Circ Physiol 277: H508–H514, 1999.[Abstract/Free Full Text]
11. Kuchan MJ, Jo H, and Frangos JA. Role of G proteins in shear stress-mediated nitric oxide production by endothelial cells. Am J Physiol Cell Physiol 267: C753–C758, 1994.[Abstract/Free Full Text]
12. Mochizuki S, Goto M, Chiba Y, Ogasawara Y, and Kajiya F. Flow dependence and time constant of the change in nitric oxide concentration measured in the vascular media. Med Biol Eng Comput 37: 497–503, 1999.[ISI][Medline]
13. Pohl U, Herlan K, Huang A, and Bassenge E. EDRF-mediated shear-induced dilation opposes myogenic vasoconstriction in small rabbit arteries. Am J Physiol Heart Circ Physiol 261: H2016–H2023, 1991.[Abstract/Free Full Text]
14. Tsunekawa T, Hayashi T, Kano H, Sumi D, Matsui-Hirai H, Thakur NK, Egashira K, and Iguchi A. Cerivastatin, a hydroxymethylglutaryl coenzyme A reductase inhibitor, improves endothelial function in elderly diabetic patients within 3 days. Circulation 104: 376–379, 2001.[Abstract/Free Full Text]
15. Van den Berg BM, Vink H, and Spaan JAE. The endothelial glycocalyx protects against myocardial edema. Circ Res 92: 592–594, 2003.[Abstract/Free Full Text]
16. Vink H, Constantinescu AA, and Spaan JAE. Oxidized lipoproteins degrade the endothelial surface layer: implications for platelet-endothelial cell adhesion. Circulation 101: 1500–1502, 2000.[Abstract/Free Full Text]
17. Vink H and Duling BR. Capillary endothelial surface layer selectively reduces plasma solute distribution volume. Am J Physiol Heart Circ Physiol 278: H285–H289, 2000.[Abstract/Free Full Text]

This article has been cited by other articles:

				J. M. Tarbell and E. E. Ebong The Endothelial Glycocalyx: A Mechano-Sensor and -Transducer Sci. Signal., October 7, 2008; 1(40): pt8 - pt8. [Abstract] [Full Text] [PDF]

				M. F. Flessner Distributed model of peritoneal transport: implications of the endothelial glycocalyx Nephrol. Dial. Transplant., July 1, 2008; 23(7): 2142 - 2146. [Full Text] [PDF]

				M.I.M. Noble, A.J. Drake-Holland, and H. Vink Hypothesis: arterial glycocalyx dysfunction is the first step in the atherothrombotic process QJM, July 1, 2008; 101(7): 513 - 518. [Abstract] [Full Text] [PDF]

				M. Nieuwdorp, M. C. Meuwese, H. L. Mooij, C. Ince, L. N. Broekhuizen, J. J. P. Kastelein, E. S. G. Stroes, and H. Vink Measuring endothelial glycocalyx dimensions in humans: a potential novel tool to monitor vascular vulnerability J Appl Physiol, March 1, 2008; 104(3): 845 - 852. [Abstract] [Full Text] [PDF]

				A. P. Stevens, V. Hlady, and R. O. Dull Fluorescence correlation spectroscopy can probe albumin dynamics inside lung endothelial glycocalyx Am J Physiol Lung Cell Mol Physiol, August 1, 2007; 293(2): L328 - L335. [Abstract] [Full Text] [PDF]

				Y. Yao, A. Rabodzey, and C. F. Dewey Jr. Glycocalyx modulates the motility and proliferative response of vascular endothelium to fluid shear stress Am J Physiol Heart Circ Physiol, August 1, 2007; 293(2): H1023 - H1030. [Abstract] [Full Text] [PDF]

				R. F. Kelly and H. M. Snow Characteristics of the response of the iliac artery to wall shear stress in the anaesthetized pig J. Physiol., July 15, 2007; 582(2): 731 - 743. [Abstract] [Full Text] [PDF]

				J. W.G.E. VanTeeffelen, J. Brands, C. Jansen, J. A.E. Spaan, and H. Vink Heparin Impairs Glycocalyx Barrier Properties and Attenuates Shear Dependent Vasodilation in Mice Hypertension, July 1, 2007; 50(1): 261 - 267. [Abstract] [Full Text] [PDF]

				P. Cabrales, B. Y. S. Vazquez, A. G. Tsai, and M. Intaglietta Microvascular and capillary perfusion following glycocalyx degradation J Appl Physiol, June 1, 2007; 102(6): 2251 - 2259. [Abstract] [Full Text] [PDF]

				S. Bertuglia, F. M. Veronese, and G. Pasut Polyethylene glycol and a novel developed polyethylene glycol-nitric oxide normalize arteriolar response and oxidative stress in ischemia-reperfusion Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1536 - H1544. [Abstract] [Full Text] [PDF]

				B. van den Berg and H. Vink Glycocalyx perturbation: cause or consequence of damage to the vasculature? Am J Physiol Heart Circ Physiol, June 1, 2006; 290(6): H2174 - H2175. [Full Text] [PDF]

				R. Kelly, T. Ruane-O'Hora, M. I. M. Noble, A. J. Drake-Holland, and H. M. Snow Differential inhibition by hyperglycaemia of shear stress- but not acetylcholine-mediated dilatation in the iliac artery of the anaesthetized pig J. Physiol., May 15, 2006; 573(1): 133 - 145. [Abstract] [Full Text] [PDF]

				B. M. van den Berg, J. A. E. Spaan, T. M. Rolf, and H. Vink Atherogenic region and diet diminish glycocalyx dimension and increase intima-to-media ratios at murine carotid artery bifurcation Am J Physiol Heart Circ Physiol, February 1, 2006; 290(2): H915 - H920. [Abstract] [Full Text] [PDF]

				D. Mehta and A. B. Malik Signaling Mechanisms Regulating Endothelial Permeability Physiol Rev, January 1, 2006; 86(1): 279 - 367. [Abstract] [Full Text] [PDF]

				M. Gouverneur, J. A. E. Spaan, H. Pannekoek, R. D. Fontijn, and H. Vink Fluid shear stress stimulates incorporation of hyaluronan into endothelial cell glycocalyx Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H458 - H452. [Abstract] [Full Text] [PDF]

				J. W. G. E. VanTeeffelen, S. Dekker, D. S. Fokkema, M. Siebes, H. Vink, and J. A. E. Spaan Hyaluronidase treatment of coronary glycocalyx increases reactive hyperemia but not adenosine hyperemia in dog hearts Am J Physiol Heart Circ Physiol, December 1, 2005; 289(6): H2508 - H2513. [Abstract] [Full Text] [PDF]

				C. J. Zuurbier, C. Demirci, A. Koeman, H. Vink, and C. Ince Short-term hyperglycemia increases endothelial glycocalyx permeability and acutely decreases lineal density of capillaries with flowing red blood cells J Appl Physiol, October 1, 2005; 99(4): 1471 - 1476. [Abstract] [Full Text] [PDF]

				S. Mochizuki, P. Sipkema, M. Goto, O. Hiramatsu, H. Nakamoto, E. Toyota, T. Kajita, F. Shigeto, T. Yada, Y. Ogasawara, et al. Exogenous NO suppresses flow-induced endothelium-derived NO production because of depletion of tetrahydrobiopterin Am J Physiol Heart Circ Physiol, February 1, 2005; 288(2): H553 - H558. [Abstract] [Full Text] [PDF]

				X Lu and G. S Kassab Nitric oxide is significantly reduced in ex vivo porcine arteries during reverse flow because of increased superoxide production J. Physiol., December 1, 2004; 561(2): 575 - 582. [Abstract] [Full Text] [PDF]

				M. B. Dancu, D. E. Berardi, J. P. Vanden Heuvel, and J. M. Tarbell Asynchronous Shear Stress and Circumferential Strain Reduces Endothelial NO Synthase and Cyclooxygenase-2 but Induces Endothelin-1 Gene Expression in Endothelial Cells Arterioscler. Thromb. Vasc. Biol., November 1, 2004; 24(11): 2088 - 2094. [Abstract] [Full Text] [PDF]

				A. Ueda, M. Shimomura, M. Ikeda, R. Yamaguchi, and K. Tanishita Effect of glycocalyx on shear-dependent albumin uptake in endothelial cells Am J Physiol Heart Circ Physiol, November 1, 2004; 287(5): H2287 - H2294. [Abstract] [Full Text] [PDF]

				S. M. Ponik and F. M. Pavalko Formation of focal adhesions on fibronectin promotes fluid shear stress induction of COX-2 and PGE2 release in MC3T3-E1 osteoblasts J Appl Physiol, July 1, 2004; 97(1): 135 - 142. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) All Versions of this Article: 285/2/H722    most recent 00691.2002v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (43) Citing Articles via Google Scholar Google Scholar Articles by Mochizuki, S. Articles by Kajiya, F. Search for Related Content PubMed PubMed Citation Articles by Mochizuki, S. Articles by Kajiya, F.